The launch of HA filler in 바카라 next year…Hosted education session for key 바카라n doctors
[by Jin, Yu Jeong] 바카라 of Huons Group held an on-site networking session with its partner and Russian key doctors ahead of the upcoming launch of its hyaluronic acid (HA) filler in the Russian market.
Humedix Co., Ltd. announced on November 7 that the company invited executives and staff members from its Russian partner Bella-Systech and key doctors from Russia and held ‘Elravie Russia Academy’ on November 6.
바카라 hosted this special on-site meeting to celebrate the upcoming launch of its HA filler in the Russian market. This event aimed to strengthen partnership with Russian partner and demonstrate the superior competitiveness of 바카라 products to local key doctors.
In the morning, delegates visited Beauty Bar Plastic Surgery Clinic in Gangnam to attend a theoretical lecture and live demonstration of ‘Elravie Premier Filler’. Dr. Eun Yeon Kim, delivered a lecture on ‘The rheological properties and sterilization processes unique to Elravie Premier Filler’. She also gave a hands-on demonstration, sharing insights and know-hows for safe and effective mid-to-lower face procedures.
Following the academy program, delegates toured Humedix’s R&D center in Gwacheon and the Huons Group’s showroom, gaining a deeper understanding of Humedix’s history and innovative technologies.
Bella-Systech is a distribution company that supplies a diverse portfolio of products, including aesthetic fillers, skin boosters, and medical devices, to medical institutions in Russia and the Commonwealth of Independent States (CIS). 바카라 will work in collaboration with Bella-Systech to officially launch high-quality HA fillers in the Russian market starting next year. Beginning with this initiative, 바카라 plans to further expand its export volume and regional footprint across Russia and Central Asia.
Humedix CEO Kang Min-Jong said, “This on-site meeting served as an opportunity for Humedix to share its global vision and technological excellence, helping to build trust with international partners. Humedix is committed to ongoing collaboration with key doctors worldwide to further strengthen its credibility in the global market.”